发明名称 IMMUNOMODULATOR PEPTIDES, NUCLEOTIDE SEQUENCE ANTIBODY AND PHARMACEUTICAL COMPOSITION
摘要 The invention relates to polypeptides different from the human interleukin, having at least one of the following properties: induce the inhibition of spontaneous IL-8 production by the human monocytes, induce the inhibition of production of IL-8 which induces IL-1 beta by the human peripheral blood mononuclear cells, induce the production of interleukin-1 receptor antagonist protein by human monocytes, induce the chemotactic migration of CD 8 + human T lymphocytes in vitro, desensitize the human CD 8 + T cells in vitro, desensitize the human CD 8 + T cells, resulting in an unresponsiveness thereof to rhIL-10, suppress the chemotactic response of CD 4 + human T-lymphocytes to IL-8, suppress the chemotactic response of human monocytes to MCA F/MCP-1, do not inhibit class II MHC molecules with expression of human monocytes, in contrast to human IL-10, induce the production of IL-4 by culturing normal human CD 4 + T cells, reduce the TNF alpha production in humans mixed leukocyte reaction. The invention relates especially to non-peptides Ala-Tyr-Met-Thr-Met-Lys-Ile-Arg-Asn, to analogues and variants thereof.
申请公布号 RO118758(B1) 申请公布日期 2003.10.30
申请号 RO19970000008 申请日期 1995.06.07
申请人 NYCOMED DAK A/S 发明人 GRONHOJ LARSEN CHRISTIAN;GESSER BORBALA
分类号 C12N15/09;A61K38/00;A61K38/20;A61K39/00;A61K39/395;A61P31/12;A61P35/00;A61P37/02;A61P37/04;A61P43/00;C07K7/06;C07K14/52;C07K14/54;C07K16/24;C12N15/00;C12N15/24;C12P21/08;C12R1/91;(IPC1-7):C12N15/24 主分类号 C12N15/09
代理机构 代理人
主权项
地址